The ability of dendritic cells to drive immune responses has led researchers to target these cells in vaccination therapy. Here, the authors review the development of the field, fromex vivo loading studies to in vivotargeting using specific receptors.
- Paul J. Tacken
- I. Jolanda M. de Vries
- Carl G. Figdor
